Bo Lagerqvist

9.4k total citations · 1 hit paper
103 papers, 5.8k citations indexed

About

Bo Lagerqvist is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bo Lagerqvist has authored 103 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Cardiology and Cardiovascular Medicine, 56 papers in Surgery and 45 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bo Lagerqvist's work include Acute Myocardial Infarction Research (68 papers), Coronary Interventions and Diagnostics (51 papers) and Cardiac Imaging and Diagnostics (43 papers). Bo Lagerqvist is often cited by papers focused on Acute Myocardial Infarction Research (68 papers), Coronary Interventions and Diagnostics (51 papers) and Cardiac Imaging and Diagnostics (43 papers). Bo Lagerqvist collaborates with scholars based in Sweden, Netherlands and United Kingdom. Bo Lagerqvist's co-authors include Lars Wallentin, Eva Swahn, Stefan James, Bertil Lindahl, Per Venge, Steen Husted, Tomas Jernberg, Ulf Stenestrand, Robbert J. de Winter and Elisabeth Ståhle and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Bo Lagerqvist

101 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)

2010 570 citations Tomas Jernberg, Kristina Hambræus et al. Heart profile →

Peers

Countries citing papers authored by Bo Lagerqvist

Since Specialization

Citations

This map shows the geographic impact of Bo Lagerqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Lagerqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Lagerqvist more than expected).

Fields of papers citing papers by Bo Lagerqvist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Lagerqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Lagerqvist. The network helps show where Bo Lagerqvist may publish in the future.

Co-authorship network of co-authors of Bo Lagerqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Lagerqvist. A scholar is included among the top collaborators of Bo Lagerqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Lagerqvist. Bo Lagerqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of coronary stenosis after adjuvant radiotherapy for breast cancer 2022 ·Strahlentherapie und Onkologie ·Anna-Karin Wennstig, Hans Garmo, (unknown), Bo Lagerqvist, Irma Fredriksson, Lars Holmberg, Carl Blomqvist, Gunnar Nilsson, Malin Sund	11
2	Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report 2021 ·Catheterization and Cardiovascular Interventions ·Per Grimfjärd, (unknown), Sergio Buccheri, David Erlinge, Bo Lagerqvist, Bodil Svennblad, Sebastian Völz, Oskar Angerås, Stefan James	4
3	Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease 2021 ·Journal of Nuclear Cardiology ·Tanja Kero, Antti Saraste, Bo Lagerqvist, Jens Nørkær Sørensen, (unknown), Mark Lubberink, Juhani Knuuti	6
4	Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function 2018 ·Heart ·Robert Edfors, Anders Sahlén, Karolina Szummer, Henrik Renlund, Marie Evans, Juan Jesús Carrero, Jonas Spaak, Stefan James, Bo Lagerqvist, Christoph Varenhorst, Tomas Jernberg	27
5	Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and Prognosis 2018 ·The American Journal of Medicine ·Anna M. Nordenskjöld, Bo Lagerqvist, Tomasz Baron, Tomas Jernberg, Nermin Hadziosmanovic, Harmony R. Reynolds, Per Tornvall, Bertil Lindahl	45
6	Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes 2017 ·American Heart Journal ·(unknown), Karl Andersen, Inga S. Þráinsdóttir, Stefan James, Bo Lagerqvist, Þórarinn Guðnason	37
7	Abstract 13206: Culprit and Non-Culprit Recurrent Ischemic Events in Post-Myocardial Infarction Patients: Data From SWEDEHEART 2016 ·Circulation ·Christoph Varenhorst, Saga Johansson, Pål Hasvold, Magnus Janzon, Per Albertsson, Margrét Leósdóttir, Kristina Hambræus, Stefan James, Tomas Jernberg, Bodil Svennblad, Bo Lagerqvist	0
8	Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial 2016 ·BMC Cardiovascular Disorders ·Göran Olivecrona, Bo Lagerqvist, Ole Fröbert, Þórarinn Guðnason, Michael Mæng, Truls Råmunddal, (unknown), Thomas Kellerth, Jason Stewart, Giovanna Sarno, Jens Jensen, Ollie Östlund, Stefan James	8
9	Effect of Gender on Patients With ST-Elevation and Non-ST-Elevation Myocardial Infarction Without Obstructive Coronary Artery Disease 2015 ·The American Journal of Cardiology ·Nina Johnston, (unknown), Christina Christersson, Tanja Kero, Henrik Renlund, Karin Schenck‐Gustafsson, Bo Lagerqvist	47
10	OUTCOME AFTER MYOCARDIAL INFARCTION IN A COHORT STUDY OF CROSS COUNTRY SKIERS IN SWEDEN 2014 ·Journal of the American College of Cardiology ·Ulf Hållmarker, Karl Michaëlsson, Johan Ärnlöv, Bo Lagerqvist, Johan Lindbäck, Stefan James	10
11	Proximal coronary artery intervention: Stent thrombosis, restenosis and death 2013 ·International Journal of Cardiology ·Fredrik Calais, Bo Lagerqvist, Jerzy Leppert, Stefan James, Ole Fröbert	11
12	Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts 2012 ·American Heart Journal ·Ole Fröbert, Fredrik Scherstén, Stefan James, J. Carlsson, Bo Lagerqvist	4
13	Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials 2011 ·Heart ·Peter Damman, Tim Clayton, Lars Wallentin, Bo Lagerqvist, Keith A.A. Fox, Alexander Hirsch, Fons Windhausen, Eva Swahn, Stuart Pocock, Jan G.P. Tijssen, Robbert J. de Winter	97
14	Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction 2010 ·Heart ·Sofia Sederholm Lawesson, Ulf Stenestrand, Bo Lagerqvist, Lars Wallentin, Eva Swahn	62
15	Prognostic Value of Biomarkers During and After Non–ST-Segment Elevation Acute Coronary Syndrome 2009 ·Journal of the American College of Cardiology ·Kai M. Eggers, Bo Lagerqvist, Per Venge, Lars Wallentin, Bertil Lindahl	63
16	Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome 2008 ·American Heart Journal ·Kai M. Eggers, Bo Lagerqvist, Jonas Oldgren, Per Venge, Lars Wallentin, Bertil Lindahl	18
17	Outcome of percutaneous coronary intervention in hospitals with and without on-site cardiac surgery standby 2006 ·Heart ·J.‐O. Carlsson, (unknown), Elisabeth Ståhle, Stefanie Hofer, Bo Lagerqvist	33
18	FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease 2005 ·Heart ·Bo Lagerqvist, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	71
19	Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? 2001 ·Journal of the American College of Cardiology ·Bo Lagerqvist, Kåge Säfström, Elisabeth Ståhle, Lars Wallentin, Eva Swahn	195
20	Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy 2001 ·Journal of the American College of Cardiology ·Bertil Lindahl, Erik Diderholm, Bo Lagerqvist, Per Venge, Lars Wallentin	197

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact